KALVISTA PHARMACEUTICALS
(483497103)
ファンドの報告 KALVISTA PHARMACEUTICALS 13F提出書類による
| 商号 | 保有株式/元本 | 市場価格 | オプション | 報告期間 | 有効日 |
|---|---|---|---|---|---|
| SV Health Investors LLC | 1,719,576 | $38,088k | Jun 30, 2019 | Aug 14, 2019 | |
| Eventide Asset Management LLC | 1,500,000 | $33,225k | Jun 30, 2019 | Aug 14, 2019 | |
| VIVO Capital LLC | 1,359,149 | $30,105k | Jun 30, 2019 | Aug 13, 2019 | |
| Deerfield Management Company LP Series C | 1,217,668 | $26,971k | Jun 30, 2019 | Aug 14, 2019 | |
| Ghost Tree Capital LLC | 300,000 | $6,645k | Jun 30, 2019 | Aug 14, 2019 | |
| Acuta Capital Partners LLC | 213,000 | $4,718k | Jun 30, 2019 | Aug 14, 2019 | |
| Point72 Asset Management LP | 162,900 | $3,608k | Jun 30, 2019 | Aug 14, 2019 | |
| Dafna Capital Management LLC | 24,725 | $548k | Jun 30, 2019 | Aug 14, 2019 | |
| Sectoral Asset Management Inc | 17,551 | $389k | Jun 30, 2019 | Aug 14, 2019 | |
| Prelude Capital Management LLC | 69 | $2k | Jun 30, 2019 | Aug 14, 2019 |